Lupin logo

LUPIN - Lupin News Story

₹1079.45 30.2  2.9%

Last Trade - 09/04/21

Sector
Healthcare
Size
Large Cap
Market Cap £4.78bn
Enterprise Value £4.99bn
Revenue £1.49bn
Position in Universe 83rd / 3106

BRIEF-Lupin Gets U.S. FDA Approval For Its Penicillamine Tablets

Tue 1st December, 2020 11:30am
Dec 1 (Reuters) - Lupin Ltd  LUPN.NS :
    * GOT U.S. FDA APPROVAL FOR ITS PENICILLAMINE TABLETS USP,
250 MG

Source text for Eikon:  ID:nBSE24Rhbc 
Further company coverage:  LUPN.NS 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.